Human Biology & BioImaging
print


Breadcrumb Navigation


Content

Publications

Grzech M, Dahlhoff M, Herbach N, Habermann FA, Renner-Müller I, Wanke R, Flaswinkel H, Wolf E and Schneider MR (2010). Specific transgene expression in mouse pancreatic beta-cells under the control of the porcine insulin promoter. Mol Cell Endocrinol., 315, 219-24.

Jakob T, Köllisch GV, Howaldt M, Bewersdorff M, Rathkolb B, Müller ML, Sandholzer N, Nietschke L, Schiemann M, Mempel M, Ollert M, Neubauer A, Soewarto DA, Kremmer E, Ring J, Behrendt H and Flaswinkel H (2008). Novel mouse mutants with primarycellular immunodeficiencies generated by genome-wide mutagenesis. J Allergy ClinImmunol., 121, 179-184.

Zhou R, Flaswinkel H, Schneider R, Lahm H, Hoeflich A, Wanke R and Wolf E (2004). Insulin-like growth factor-binding protein –4 inhibits growth of the thymus in transgenic mice. J Mol Endocrinol., 32, 349-64.

Shi W, Hoeflich A, Flaswinkel H, Stojkovic M, Wolf E, and Jakhartchenko V (2003). Induction of a senescent-like phenotype does not confer the ability of bovine immortal cells to support the development of nuclear transfer embryos. Biol Reprod., 69, 301-9.

Flaswinkel H, Alessandrini F, Rathkolb B, Decker T, Kremmer E, Servatius A, Jakob T, Soewarto D, Marschall S, Fella C, Behrendt H, Ring J, Wolf E, Balling R, Hrabe de Angelis M and Pfeffer K (2000). Identification of immunological relevant phenotypes in ENU mutagenized mice. Mamm Genome, 11, 526-7.

Hrabe de Angelis MH, Flaswinkel H, Fuchs H, Rathkolb B, Soewarto D, Marschall S, Heffner S, Pargent W, Wuensch K, Jung M, Reis A, Richter T, Alessandrini F, Jakob T, Fuchs E, Kolb H, Kremmer E, Schaeble K, Rollinski B, Roscher A, Peters C, Meitinger T, Strom T, Steckler T, Holsboer F, Klopstock T, Gekeler F, Schindewolf C, Jung T, Avraham K, Behrendt H, Ring J, Zimmer A, Schughart K, Pfeffer K, Wolf E, and Balling R (2000). Genome-wide, large-scale production of mutant mice by ENU mutagenesis. Nat Genet, 25, 444-7.

Adachi T, Flaswinkel H, Yakura H, Reth M and Tsubata T (1998). The B cell surface protein CD72 recruits the tyrosine phosphatase SHP-1 upon tyrosine phosphorylation. J Immunol., 160, 4662-5.

Bewarder N, Weinrich V, Budde P, Hartmann D, Flaswinkel H, Reth M and Frey J (1996). In vivo and in vitro specificity of protein tyrosine kinases for immunoglobulin G receptor (FcgRII) phosphorylation. Mol Cell Biol, 16, 4735-4743.

Torres RM, Flaswinkel H, Reth M and Rajewsky K (1996). Aberrant B cell development and immune response in mice with a compromised B-cell antigen receptor complex. Science, 272 1804-1808.

Yao XR, Flaswinkel H, Reth M and Scott DW (1995). The Immunoreceptor tyrosine-based activation motif (ITAM) is required for signal pathways of receptor-mediated growth arrest and apoptosis in murine B-lymphoma cells. The Journal of Immunology, 155, 652-661.

Flaswinkel H, Barner M and Reth M (1995). The tyrosine activation motif (TAM) as a target of PTKs and SH2 domains. Seminars in Immunology, 7, 21-27.

Flaswinkel H and Michael Reth M (1994). Dual role of the tyrosine activation motif of the Ig- protein during signal transduction via the B-cell antigen receptor. EMBO J., 13, 83-89.

Iglesias A, Nichogiannopoulou A, Williams SG, Flaswinkel H and Köhler G (1993). Early B cell development requires m signaling. Eur. J. Immunol., 23, 2622-2630.

Flaswinkel H and Reth M (1992). Molecular cloning of the Ig-alpha subunit of the human B-cell anitgen receptor complex. Immunogenetics, 36, 266-269.